| Editorial |
Information
has Value
Britton KE |
| Commentary |
Cancer
patients undertaking Bone Scans in a Department
of Nuclear Medicine have Significant Stress
Related to the Examination
Sioka C, Christidi S, Kouraklis
G , Manetou M, Dimakopoulos N |
| In vivo
Diagnostics |
Clinical
Usefulness of Attenuation and Scatter Correction
on Tl-201 SPECT Studies using Coronary Angiography
as a Reference
Velidaki A, Perisinakis K, Koukouraki
S, Koutsikos J, Vardas P, Karkavitsas N
|
| |
Role
of Tc-99m Sulesomab in the Diagnosis of
Bone and Joint Infections
Iyengar KP, Nadkarni JB, Vinjamuri
S |
| |
Assessing
Tubular Damage due to Cisplatin Nephrotoxicity,
using Tc-99m MAG3
Sohaib M, Zehra T, Saeed
S , Yousuf M, Khan AN |
| |
Leakage
Monitoring during Isolated Limb Perfusion:
Comparison of Two Radioisotopic Techniques
in a Patient with Malignant Melanoma.
Sapienza
MT, Campos-Neto GC, Oliveira MAC, Akaishi
E, Watanabe T, Ono CR, Costa PLA, Rodrigues
CJ, Rodrigues Jr. AJ, Buchpiguel CA |
| Radiopharmacy |
Oxotechnetium
and Oxorhenium 3+1 Mixed Ligand Complexes
as Potential Melanoma Targeting Agents
Rey
A, Pirmettis I, Papadopoulos M, Giglio J,
Leon E, Schreiber F, Paolino A, Fernandez
R, Manta E, Chabalgoity J, Leon A |
| Experimental |
The
placental binding and transfer of radiopharmaceuticals
II: Tc-99m Sestamibi, Tc-99m Tetrofosmin
and Tl-201 Thallous Chloride
Owunwanne
A, Nandakumaran M, Fielding H, Omu A, Gopinath
S, George S, Mathew M |
| Review |
Nuclear
Medicine imaging of infection and inflammation
Part 3: Clinical applications
Gnanasegaran
G, Croasdale J, Buscombe JR |
Window
on World Radiopharmaceutical Therapy
Council |
International
Conference on Radiopharmaceutical Therapy |
